Question: Can we expect an announcement soon concerning the upcoming drilling program at the Yeoval project? Or do we have to wait for the infill soil sampling program to be completed before planning for the Yeoval drilling program can be undertaken?
The ann. from 2 March 2023 stated:
- High resolution ground magnetic surveys have been completed across the Cyclops, Yeoval East
and Goodrich Prospects, assisting with the definition of drill targets
- Infill soil sampling programs are being carried out across both the Goodrich and Yeoval East
Prospects and are planned to be completed before the end of Q2 2023
- A comprehensive drill program, partially supported by recently secured NSW New Frontiers Drilling
Grant funding, will be undertaken on all three prospects
We know the following:
1. Both the rock chip assays and the high-resolution ground magnetic surveys have been completed.
2. All 3 prospects (Cyclops, Goodrich, and Yeoval East) at the Yeoval project will be drilled.
But what I'm not sure about is the infill soil sampling programs. The ann. stated that these programs are due to be completed by the end of Q2. So does that mean that planning for Yeoval drilling program is contingent on these infill results and therefore the drilling program cannot commence before these results are received by GRL? Or can the planning and the drilling program proceed without these results?
Does anyone have any information/thoughts on this issue? I would really appreciate your input.
I am very excited (and impatient) for GRL to really get stuck into its Yeoval Project. As I've stated previously, IMO, GRL's LFB tenements hold tremendous copper/gold porphyry potential.
- Forums
- ASX - By Stock
- GRL
- Ann: High grade copper in rock chips at Cyclops and Goodrich
GRL
godolphin resources limited
Add to My Watchlist
11.1%
!
1.0¢

Ann: High grade copper in rock chips at Cyclops and Goodrich, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $4.488M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.9¢ | $5.188K | 537.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 3303193 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 241273 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 3247637 | 0.009 |
8 | 2785000 | 0.008 |
6 | 1756627 | 0.007 |
4 | 966833 | 0.006 |
3 | 2020000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 241273 | 2 |
0.011 | 1933562 | 3 |
0.012 | 1010000 | 2 |
0.013 | 636419 | 8 |
0.014 | 172400 | 3 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
GRL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online